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Abstract 
Dietary nitrate (found in green leafy vegetables such as rocket and in beetroot) is now 
recognised to be an important source of nitric oxide, via the nitrate-nitrite-NO pathway. 
Dietary nitrate confers several cardiovascular beneficial effects on blood pressure, platelets, 
endothelial function, mitochondrial efficiency and exercise. Having described key twists and 
turns in the elucidation of the pathway and the underlying mechanisms in Part I, we explore 
the more recent developments which have served to confirm mechanisms, extend our 
understanding, and discover new properties and potential therapeutic uses of the Pathway in 
Part II. Even the established dependency on low oxygen states for bioactivation of nitrite has 
recently been challenged. Dietary nitrate appears to be an important component of ‘healthy 
diets’, such as the DASH diet to lower blood pressure and the Mediterranean diet, with its 
potential to lower cardiovascular risk, possibly through beneficial interactions with a range of 
other constituents. The World Cancer Research Foundation report strong evidence for 
vegetables including spinach and lettuce (high nitrate-containing) decreasing cancer risk 
(mouth, pharynx, larynx, oesophagus and stomach), summarised in a ‘Nitrate-Cancer Risk 
Veg-Table’. The European Space Agency recommends beetroot, lettuce, spinach and rocket 
(high-nitrate vegetables) are grown to provide food for long term space missions. Nitrate, an 
ancient component of rocket fuel, could support sustainable crops for healthy humans. 
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Introduction 
In Part I we described how the nitrate-nitrite-NO pathway was initially established. In Part II 
we address the more recent developments which have served to confirm mechanisms, 
extend our understanding, and discover new properties and potential therapeutic uses of the 
Pathway. 
 
11. Is nitrate protective in IRI?  
Having previously discovered the protective effects of inorganic nitrite in a model of 
ischaemia-reperfusion injury (IRI) in the isolated perfused rat heart (Langendorff preparation) 
[1], Webb et al. performed a translational study to determine whether beetroot juice, as a 
source of dietary nitrate-derived nitrite, could protect against transient endothelial 
stunning/dysfunction induced by a model of IRI in the forearm of  healthy humans (20 
minutes ischaemia and 20 minutes reperfusion), with endothelial function determined by 
flow-mediated dilatation (FMD) [2]. Whilst beetroot juice had no effect on FMD prior to the 
ischaemic insult, the nitrate source preserved endothelial function following IRI, compared to 
control, in which a 60% suppression of FMD response was observed. That the protective 
effect was due to inorganic nitrate-derived nitrite was confirmed by Kapil et al. using 
potassium nitrate instead of beetroot juice [3]. Therefore, protection against IRI, at least in 
terms of endothelial dysfunction is also conferred by readily administered sources of dietary 
or inorganic nitrate as a source of nitrite, besides directly-applied nitrite.  
 
12. Does nitrite inhibit platelets?  
Given that nitrate had previously been shown to inhibit platelet aggregation, and that dietary 
nitrate had now been shown to result in an increase in circulating nitrite levels, it was 
possible that the antiplatelet effects of nitrate were mediated by nitrite. As part of a wider 
study to explore the biological activity of nitrite in normal physiology, Bryan et al. measured 
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ex-vivo platelet aggregation to ADP from venous blood of rats following intraperitoneal 
administration of nitrite (0.1, 1 or 10 mg/kg) [4]. They found that platelet aggregability 
remained unchanged, or even increased, following nitrite administration. The authors 
proposed that this lack of inhibition of platelet aggregation, suggested that metabolism of 
nitrite to NO within the circulation was likely to be limited under a physiological oxygen 
gradient.  
Webb et al. examined the effects of nitrite on adenosine diphosphate (ADP) or collagen-
induced platelet aggregation by interrupting the enterosalivary circulation in the spit versus 
swallowing of saliva study, following beetroot juice consumption [2].  As expected, a 
significant reduction in aggregation was apparent when volunteers swallowed their saliva 
normally following the consumption of beetroot juice; an effect that was associated with a 
significant increase in plasma nitrite concentration. However, when volunteers spat out all 
their saliva for 3 hours, plasma nitrite concentration did not increase, and there was no 
change in either ADP- or collagen-induced platelet aggregation following beetroot juice 
consumption. Whilst the antiplatelet effects of dietary nitrate/beetroot juice were predictable 
from previous studies, that this was due to nitrite (as demonstrated by interrupting the 
enterosalivary circulation), was not. Indeed, a trend to the opposite effect of nitrite had been 
suggested by the study in rats [4]. The effect of nitrite on inhibition of platelet aggregation in 
humans was confirmed by Velmurugan et al. with direct spiking of ex vivo blood with 
potassium nitrite, and in vivo following acute nitrate consumption, an effect associated with a 
reduced platelet P-selectin expression [5]. However, this effect was non-significant in 
females, which concurs with the previous study by Kapil et al., reflecting differences in 
baseline nitrite [3]. Velmurugan et al. have subsequently demonstrated the longer term 
effects of 6 weeks’ ingestion of dietary nitrate (active beetroot juice) versus nitrate-depleted 
placebo beetroot juice in 67 patients with hypercholesterolaemia, resulting in reductions in 
monocyte platelet aggregates in addition to stimulated (ex vivo) P-selectin expression [6]. 
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13. Does nitrate/nitrite exhibit tolerance? 
Tolerance to organic nitrates such as GTN is a commonly observed phenomenon that 
occurs with their continuous application, resulting in a reduction in their therapeutic efficacy 
[7, 8].  It is therefore possible that inorganic nitrate and nitrite would have the same problem. 
However, Dejam et al., found no evidence of tolerance for acute blood pressure reductions 
with daily boluses of inorganic (sodium) nitrite on a background of a continuous infusion of 
nitrite over 14 days [9]. Similarly, several studies support an absence of tolerance issues 
with dietary nitrate. Sobko et al., (2010) showed a sustained reduction in diastolic BP of ~4.5 
mmHg over 10 days, with a high-nitrate Japanese Traditional Diet, compared to a low-nitrate 
control diet [10]. In the same year, Vanhatalo et al. reported that the blood pressure-lowering  
effects of daily beetroot juice persisted over a two-week period in healthy volunteers [11]. 
Kapil et al. performed a randomised, double-blind, placebo-controlled parallel-group trial in 
which 68 patients, half of whom with treated hypertension, and the other half with untreated 
hypertension, received a dietary nitrate (250 ml beetroot juice) or placebo (nitrate-free 
beetroot juice) daily over a 4-week period [12]. They found a significant and sustained blood 
pressure-lowering response to dietary nitrate, which was similar across all 3 methods of 
measurement: clinic blood pressure: 7.7/2.4 mmHg, 24-hour ambulatory blood pressure: 
7.7/5.2 mm Hg, and home BP 8.1/3.8 mm Hg. For home blood pressures, there was a trend 
to a greater blood pressure-lowering effect over time. This suggests that dietary nitrate does 
not exhibit tolerance following daily usage. Therefore supplementation with dietary nitrate 
provides an inexpensive and effective approach to reduce blood pressure. 
 
14. Does nitrite alter mitochondrial metabolism?  
NOS-derived NO has an important and established regulatory role in the mitochondria, and 
therefore it is possible that nitrite may also have an effect, given appropriate conditions. In 
normoxia, NOS-derived NO binds reversibly to the copperB/haema3 binuclear centre of 
complex IV (Cytochrome C oxidase (CcOx)), inhibiting mitochondrial respiration by 
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competing with oxygen [13-15].  Complex IV is the terminal part of the mitochondrial chain 
which normally reduces 95% of inspired oxygen [16]. Therefore inhibition of complex IV by 
NO allows oxygen to be diverted away from the mitochondria to other targets, for example 
mediating cell signalling and oxidative stress through the generation of ROS. In 
hypoxia/ischaemia, NOS activity is inhibited in the absence of oxygen. However, nitrite can 
be reduced to NO by enzymes described above (including XOR, deoxymyoglobin) and also 
by the electron transport chain (ETC) itself, and thus can continue to regulate oxygen 
gradients via inhibition of respiration at complex IV.  However, during IRI, nitrite may also 
directly inhibit complex I via S-nitrosation, decreasing ROS generation at reperfusion [17].  
 
As Bailey et al., described, “a fundamental tenet of human exercise physiology is a 
predictable oxygen (O2) cost for a given submaximal work rate” [18]. Therefore, the ultimate 
challenge is to make mitochondrial respiration more efficient, as this would be expected to 
improve exercise performance. To this end, Larsen et al. demonstrated that supplementation 
of healthy volunteers with inorganic nitrate reduced the oxygen cost during graded 
submaximal exercise, with a significant reduction in VO2 compared to placebo [19].  Bailey et 
al. confirmed a reduction in O2 cost with dietary nitrate (beetroot juice) and that this was 
coupled with a reduction in ATP turnover, as demonstrated by a reduction in 
phosphocreatine degradation and ADP concentration [20].  The mechanism was further 
elucidated by Larsen et al. who determined the amount of oxygen consumed per ATP 
produced (P/O ratio) through skeletal muscle biopsies in humans [21].  They found a 
significant improvement of 23% in the P/O ratio following nitrate ingestion compared to 
placebo. This improvement correlated with a reduction in oxygen cost during exercise. In 
addition to effects on Complex I and IV, dietary nitrate was found to reduce the expression of 
ATP/ADP translocase, the adenine nucleotide transporter (ANT), a protein involved in proton 
conductance. Nitrate reduced proton leak into the mitochondria. This improved mitochondial 
efficiency by reducing the amount of ATP required to expel the protons. 
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The studies described above were performed under normoxic conditions. However, given 
the enhanced reduction of nitrite to bioactive NO in hypoxia, Vanhatalo et al. studied the 
effects of 750 mL of beetroot juice (9.3 mmol nitrate) ingested 24 hours prior to exercise 
under conditions of hypoxia (with subjects breathing 14.5% O2). Nitrate restored exercise 
tolerance and oxidative function to values observed in normoxia [22]. Masschelein et al. 
studied the more chronic effects of 6 days’ of beetroot juice on cycle ergometry in a hypoxia 
facility breathing 11% O2. The nitrate-containing juice reduced VO2 at rest and at 45% of 
peak O2 consumption and increased %SpO2 compared to placebo [23].  Whilst nitrate 
improved the tissue oxygenation index of muscle at rest and at 45% of peak O2 consumption 
and maximal exercise, there was no effect on cerebral tissue oxygenation index or 
symptoms of acute mountain sickness. 
 
In addition to studies performed under hypoxia in healthy volunteers, the effects of dietary 
nitrate on exercise performance have been studied in patients with important comorbidities 
associated with generalised or local hypoxia. For example, patients with peripheral arterial 
disease have impaired perfusion with local tissue hypoxia of the lower limb.  Kenjale et al., 
(2011) showed that administration of a single dose of beetroot juice (500 mL) to patients with 
peripheral arterial disease increased their time before onset of claudication by 18%, and the 
total walking time by 17%, [24]. However, Mohler et al., found no effect of sodium nitrite (40 
mg or 80 mg twice daily) taken by patients with peripheral artery disease (over half of whom 
also had type 2 diabetes) for 10 weeks on the 6-minute walk test or quality of life parameters 
[25]. 
 
Patients with chronic obstructive pulmonary disease (COPD) have skeletal muscle 
deconditioning and ventilatory and gas exchange impairments resulting in tissue hypoxia 
and lactic acidosis, and decreased exercise capacity. Therefore patients with COPD would 
appear to be a perfect group to study the potential benefits of dietary nitrate. Indeed, five 
such studies were published in 2015; however they present mixed findings. Berry et al. 
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showed that in 15 patients with COPD, beetroot juice increased the submaximal constant 
work rate exercise time at 75% of maximal work capacity [26]. The arterial oxyHb saturations 
remained ~95% throughout. Kerley et al., observed an increase in the incremental shuttle 
walk test (ISWT) distance of 25 m after 11 patients with COPD consumed the high nitrate 
juice compared with a reduction of 14 m after the low nitrate juice [27]. Here, the pre-ISWT 
arterial oxyHb saturations were ~95%, but decreased to ~89% post-ISWT. Using the 6-
minute walk test (MWT), Shepherd et al., did not find any effect of beetroot juice on the 
oxygen cost of exercise or distance covered in 13 patients with COPD [28].  Leong et al. 
found no effect of 3 days’ of beetroot juice (4.8 mmol twice a day) on the endurance shuttle 
walk test (ESWT) distance and time to fatigue at 85% VO2max in 19 patients with COPD 
[29]. Whilst Curtis et al. did not find any effect on endurance time at 70% of maximal 
workload of beetroot juice (12.9 mmol nitrate) ingested 3 hours beforehand, isotime oxygen 
consumption (VO2) was 3-4% lower following nitrate supplementation [30].  The arterial 
oxyHb saturations decreased from ~95-96% to ~93-94% with exercise. Therefore 3 of the 5 
studies found an effect of dietary nitrate. Three of the studies reported oxyHb saturations, 
with only relatively small changes. 
 
Pawlak-Chaouch et al. have very recently performed a systematic review and a meta-
analysis on the effect of dietary nitrate supplementation on metabolic rate during rest and 
exercise in humans [31].  This found that dietary nitrate supplementation significantly 
decreased VO2 during submaximal intensity exercise overall, and specifically that of 
moderate and heavy intensity exercise. However, a sub-analysis in patients with chronic 
disease did not reveal any significant effect in this group. In a further crossover study in 48 
patients with type 2 diabetes mellitus, not included in this analysis, Shepherd et al. found 
that 4 days’ supplementation with nitrate-rich beetroot juice did not reduce the O2 cost of 
walking or the distance covered in a 6MWT compared to placebo [32]. There were also no 
effects seen with blood pressure. This lack of a blood pressure effect is consistent with a 
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previous study by Gilchrist et al., which also found no effect of dietary nitrate on endothelial 
function and insulin sensitivity in patients with type 2 diabetes [33]. 
 
15. Are nitrite’s effects all hypoxia-dependent? 
In small, resistance arterioles, the extraction of oxygen by skeletal muscle, particularly 
exercising muscle, facilitates the established hypoxia-dependent reduction of nitrite to 
vasodilating NO [34]. Thus in conduit vessels - where haemoglobin is fully saturated with 
oxygen, it was expected that nitrite would have minimal, if any, vasodilatory activity. 
However, Omar et al., recently found that infusion of sodium nitrite into the brachial artery, 
with mean haemoglobin oxygen saturations of 99%, resulted in selective dilatation 
(measured by ultrasound) of the radial artery (a medium-sized conduit vessel) over 
resistance vessels (measured by forearm blood flow); this selectivity to conduit vessels 
being similar that of GTN - the most selective large artery dilator currently studied [35]. 
Furthermore, rather than being enhanced by hypoxia, radial artery dilatation to nitrite was 
markedly inhibited when participants inhaled 12% oxygen (“hypoxia” - resulting in 
haemoglobin oxygen saturations of ~90%) compared to 21% (normoxia), this was in contrast 
to the confirmation of increased forearm blood flow in hypoxia. A potential mechanism may 
be via carbonic anhydrase, as the inhibitor acetazolamide increased radial artery dilatation to 
nitrite. Carbonic anhydrase lacks a redox centre and may act as a nitrite anhydrase rather 
than a nitrite reductase, an action which may be less dependent on hypoxic/acidic/reducing 
conditions. Whilst acetazolamide inhibits the CO2 hydration reaction of carbonic anhydrase it 
may increase the nitrite anhydrase activity. The functional relevance of conduit artery 
dilatation may relate to improvement in central haemodynamics. Indeed, with intravenous 
nitrite Omar et al., found systemic conduit artery dilatation associated with selective lowering 
of central (aortic) systolic blood pressure, in addition to augmentation index and pulse wave 
velocity [35].  
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Such improvements in central haemodynamic indices may provide the explanation for the 
effect of nitrate supplementation via beetroot juice improving exercise duration by ~1 minute 
in patients with Heart Failure with Preserved Ejection Fraction (HFpEF) published in parallel 
by Zamani et al [36, 37].  Instead of finding an improvement in exercise efficiency as 
expected, oxygen consumption (VO2max) was actually increased following active nitrate-
containing beetroot juice (versus placebo) – as a result of the increased exercise capacity 
and increased cardiac output. This improved cardiac performance may have been due to a 
more favourable central haemodynamic profile and reduced after-load with nitrate as 
suggested by a reduced augmentation index.  Indeed, Borlaug et al, have subsequently 
found that in a parallel-group study versus placebo, intravenous infusion of sodium nitrite in 
patients with HFpEF reversed the increase in pulmonary capillary wedge pressure (PCWP) 
during exercise to pre-exercise levels, measured during invasive cardiac catheterisation [38]. 
This was associated with an improvement in cardiac output reserve with exercise (due to 
increased stroke volume), an increase in VO2, but also normalisation of the increase in 
cardiac output relative to oxygen consumption (ΔCO/ΔVO2), suggesting an improvement in 
efficiency.  
 
16. Is nitrate/nitrite harmful? 
Humans are exposed to nitrate and nitrite from birth, with concentrations of nitrate and nitrite 
of ~30 µM and ~20 µM respectively in colostrum [39].  This may provide an important early 
anti-infective function. Whilst nitrite concentration falls to ~0.3 µM in transition and mature 
breast milk, nitrate concentration increases to ~85 µM in transition milk, before falling to ~45 
µM in mature milk. Nitrate and nitrite were also present in the formula milks tested, although 
most with considerably lower concentrations than breast milk. From infancy onwards, 
exposure continues as nitrite (E249, E250) and nitrate (E251, E252) are widely-used EU-
approved food additives for meat preservation, to reduce pathogenic growth, most notably 
Clostridium botulinum [40], with sodium nitrite added in concentrations up to 150 mg/kg. 
 This article is protected by copyright. All rights reserved. 
However, the nitrite concentration has recently been shown to decrease by 85% within the 
first 24 hours of addition for chicken liver pate [41]. We speculate that this could be related to 
the high concentrations of xanthine oxidoreductase in liver, which will rapidly metabolise 
nitrite to NO. This contrasts with a lesser decline of ~50% in nitrite concentration for chicken 
sausage and ~65% for beef/pork sausage within the first 24 hours, although these 
concentrations were then fairly well maintained over the subsequent 2-3 weeks. Whilst 
processed meats were estimated to account for around a third of dietary nitrite exposure in a 
4 year old child, the majority of nitrite, ~60% was estimated to be derived from endogenous 
conversion of nitrate from vegetables (and drinking water).  
 
The key question for many years has been whether nitrate and nitrite cause cancer? The 
International Agency for Research on Cancer (IARC) evaluated the carcinogenic hazard to 
humans of ingested nitrate and nitrite for the first time in 2006 in the 94th volume of IARC 
Monographs [42]. It identified the reduced risks of gastric cancer from some epidemiological 
studies of high nitrate ingestion primarily from vegetables, as opposed to increased risks 
from other studies of nitrate/nitrite ingestion from nitrite-preserved meats. The mechanistic 
explanation proposed was that the formation of N-nitroso compounds is accelerated by the 
presence of nitrosatable compounds (found in meat), but inhibited by vitamin C and other 
antioxidants (abundant in vegetables). As the cancer hazard from nitrate/nitrite ingestion 
could not be determined without considering these other factors, the Working Group defined 
the agent not as “ingested nitrate or nitrite”, but as “ingested nitrate or nitrite under 
conditions that result in endogenous nitrosation”, which was categorised as probably 
carcinogenic to humans (Group 2A). This marked the first use of a mechanistic event 
(endogenous nitrosation) leading to carcinogenesis in the wording of an evaluation 
statement.   
 
Bryan et al. conducted a review of the evidence from experimental animal studies and 
human epidemiological studies on cancer risk from ingested nitrate or nitrite, emphasising 
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studies not included in, or published subsequent to the 2006 IARC evaluation. They 
concluded that, in the absence of co-administration of a carcinogenic nitrosamine precursor, 
there was no evidence for carcinogenesis. It was thought that N-nitrosamines formed in the 
acidic environment of the stomach led to cancer formation. However, this review highlights 
how N-nitrosation is an essential part of physiological cell signalling. The kinetics of the 
stomach are such that S-nitrosation is favoured, leading to the formation of RSNOs rather 
than “potentially carcinogenic” substances. They found no association between nitrate/nitrite 
intake and risk of stomach cancer [43].  
 
In fact, nitrate/nitrite may even protect individuals from cancer.  Petersson et al. found nitrate 
to be gastroprotective in rats, by regulating gastric mucosal blood flow and protecting against 
NSAID-induced damage [44]. When rats were treated with antiseptic mouthwash, this 
beneficial effect and the associated rise in plasma nitrite concentration was inhibited, 
supporting the enterosalivary circulation of nitrate as a protective factor. Apart from any 
effects due to nitrate, red beetroot extract has been shown to have anti-cancer properties 
against several cancer cell lines, including oesophagus, lung, breast, liver, prostate and skin 
[45-48] attributed to the high content of the betacyanin, betanin, being protective, possessing 
strong antioxidant activity [49].  
The 114th IARC Monograph recently classified processed meat as carcinogenic to humans 
(Group 1), based on sufficient evidence in humans that the consumption of processed meat 
causes colorectal cancer [50]. This key conclusion was based on a meta-analysis of 
colorectal cancer in ten cohort studies by [51]. This reported a statistically significant dose–
response relationship, with an 18% increase (95% CI 1·10–1·28) per 50 g per day of 
processed meat. Whilst the meta-analysis had also reported a very similar 17% increased 
risk (95% CI 1·05–1·31) per 100 g per day of red meat, the Working Group concluded that 
there was limited evidence in human beings for the carcinogenicity of the consumption of red 
meat as no clear association was seen in several of the high quality studies. However, given 
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strong mechanistic evidence supporting a carcinogenic effect, the consumption of red meat 
was classified as probably carcinogenic to humans (Group 2A). In addition, positive 
associations were identified between the consumption of processed meat with stomach 
cancer and the consumption of red meat with pancreatic and with prostate cancer. 
Processed meats are also high in salt, an established risk factor for stomach cancer. 
 
The World Cancer Research Fund Continuous Update Report (December 2015) reports 
strong evidence for non-starchy vegetables, such as broccoli, cabbage, spinach, kale, 
cauliflower, carrots, lettuce, tomatoes, leek, swede and turnip decrease the risk of cancer of 
the mouth, pharynx, larynx, oesophagus and stomach [52]. Therefore this includes several 
green leafy vegetables that are high in dietary nitrate and which appear to decrease the risk 
of cancer of the upper gastrointestinal tract – particularly the oesophagus and stomach, 
where the greatest concern is; see the ‘Nitrate-Cancer Risk Veg-Table’ (Table 1). 
Specifically, decreased oesophageal cancer is associated with foods containing vitamin C. 
Vitamin C/Ascorbic acid is known to inhibit N-nitrosamine formation [53]. Vermeer et al. 
showed that ascorbic acid (250 mg and 1 g) profoundly inhibited N-nitrosodimethylamine 
(NDMA) excretion in 25 women consuming a fish meal rich in amines as nitrosatable 
precursors, in combination with nitrate-containing drinking water at the Acceptable Daily 
Intake (ADI) over 7 consecutive days [54]. Chung et al. also showed that whole strawberries, 
garlic juice, and kale juice all independently inhibited NDMA excretion in 27 males and 13 
females following nitrate (400 mg/day) in combination with an amine-rich diet [55]. Of note, 
kale itself contains a moderately high amount of nitrate [56] and therefore this result is 
despite the additional nitrate load. The effect of these fruits and vegetables is unlikely to be 
due solely to ascorbic acid. For example, Helser et al. found that ascorbic acid (46 mg in 100 
ml water) only inhibited nitrosamine formation (as assessed by the N-nitrosoproline (NPRO) 
test) by 24% compared with  41–63% following ingestion of juices (100 ml) made of green 
pepper, pineapple, strawberry, or carrot containing an equal total amount of ascorbic acid 
[57]. Other compounds that may be involved include polyphenols [58]. Indeed, Gago et al. 
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have demonstrated an interesting role for red-wine polyphenols in enhancing nitrite reduction 
to NO [59]. 
 
17. Other therapeutic opportunities for nitrate-nitrite 
The Review has mainly focused on the effects of nitrate and nitrite on IRI, blood pressure, 
platelet function, mitochondrial function and exercise as these findings were pivotal to 
defining the nitrate-nitrite-NO pathway. However, the pathway involves almost all organs and 
systems and there is a rapidly expanding range of mechanisms and effects being reported 
for nitrate and nitrite, with associated potential therapeutic opportunities for their use in 
health and disease. For example, Pluta et al., found that the intravenous infusion of sodium 
nitrite prevented delayed cerebral vasospasm in a primate model of acute subarachnoid 
haemorrhage (SAH) [60]. This finding has been translated into a phase IIa study, which 
demonstrated the safety of nitrite in patients following SAH, administering doses up to 64 
nmol/kg/min; although patient numbers were too small to draw any conclusions about clinical 
efficacy [61]. Following beneficial effects of nebulised nitrite [62], and also dietary nitrate in 
models of pulmonary arterial hypertension [63], and favourable kinetics and safety of 
nebulised nitrite over 6 days in healthy humans [64], this therapeutic approach has been 
advanced into randomised trials in patients with pulmonary arterial hypertension. 
Beyond the use of nitrite as a preservative in meat to reduce pathogenic growth as 
described above, nitrite has the potential to inhibit bacterial growth in humans, related to the 
antimicrobial activity of NO. For example, many opportunistic organisms that occupy the 
lower urinary tract (e.g. E. coli) possess nitrate reductase enzymes, forming the basis of 
urine dipstick detection of nitrites (see Figure 2 in Part I of the Review). In acidic 
environments, nitrite is reduced to NO and can be highly toxic to bacteria. Carlsson et al. 
found that the transfer of nitrite-rich urine containing E. coli to a more acidic environment 
(e.g. pH 5.5) effectively inhibited bacterial growth, in a dose dependent manner [65]. This 
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effect was potentiated in the presence of vitamin C. The antibacterial potency of this method 
was comparable to conventional antibiotics such as trimethoprim and nitrofurantoin.  
Within the airways, in an animal model of cystic fibrosis (CF), acidified nitrite (pH <7) has 
been demonstrated to clear the deadly bacterium mucoid Pseudomonas aeruginosa (P. 
aeruginosa), commonly found in patients with CF [66]. P. aeruginosa is often refractory to 
therapy and therefore, nitrite offers an alternative solution to treating this pathogen. More 
recently, Zemke et al., have shown that sodium nitrite prevents 99% of biofilm growth of P. 
aeruginosa on the apical surface of primary human airway epithelial cells [67]. This may 
represent an additional use for nebulised nitrite, possibly in combination with polymixins 
where there is evidence of an enhanced effect [67].  However, this was not the case with the 
gentamicin and tobramycin, where sodium nitrite was found to induce resistance to both 
aminoglycosides of P. aeruginosa grown in liquid culture, or as abiotic, or biotic biofilms [68]. 
 
18. Are there potentially beneficial dietary combinations? 
We have primarily focused on the specific properties of nitrate and nitrite. However, their 
interactions with other nutrients are of importance when one considers them in the context of 
healthy diets such as the Mediterranean diet, where the beneficial effects are unlikely to 
relate to a single component; this is also relevant to approaches to minimise the risk of 
cancer. Such combinations are summarised in Table 2. For example, in Part I we described 
the importance of ascorbic acid as a reducing agent to enhance NO production from nitrite, 
and thus maximise nitrite’s activity, in terms of vasorelaxation [69]. At least as important as 
this property, is ascorbic acid’s effect in inhibiting N-nitrosamine formation [53], to decrease 
the risk of gastro-oesophageal cancer [52]. 
 
The Mediterranean diet is rich in unsaturated fatty acids, such as oleic acid, present in olive 
oil, and conjugated linoleic acid (CLA), produced in the ruminant stomach and found in dairy 
products such as milk and cheese. These fatty acids are nitrated by nitrous acid, derived 
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from nitrite in the acid environment of the stomach, forming the nitro-fatty acids (NO2-FAs) 
nitro-oleic acid and nitro-linoleic acid, respectively [70]. Nitro-fatty acids are found in the 
circulation in nanomolar to low micromolar concentrations [71]. Nitro-fatty acids have 
important anti-inflammatory properties.  For example, Borniquel et al., showed that orally 
administered nitro-oleic acid was effective in suppressing inflammation in experimental 
inflammatory bowel disease [72], with an action through peroxisome proliferator-activated 
receptor-γ (PPAR-γ) [72, 73]. Inhibition of macrophage cytokine and iNOS expression has 
been demonstrated through S-alkylation of nuclear factor κB [74]. Through a mechanism 
involving reduced foam cell formation and oxidised LDL-induced phosphorylation of signal 
transducer and activator of transcription-1 (STAT-1), Rudolph et al., demonstrated reduced 
atherosclerotic lesion formation following subcutaneous injection of nitro-oleic acid in 
apoliproprotein E-deficient mice [75].  In addition to their enhanced formation under 
conditions of hypoxia [76], and during IRI [77, 78], administration of exogenous nitro-fatty 
has protective properties in IRI, increasing expression of the antioxidant enzyme heme 
oxygenase-1 (HO-1), elevating MicroRNA-499 (miRNA-499) levels, and abolishing the 
expression of p53 and dynamin-related protein-1 (DRP-1) normally expressed in cardiac 
tissue post-IRI [79]. Charles et al., demonstated the inhibition of soluble epoxide hydrolase 
(sEH) with mice fed oral CLA and nitrite, and following the systemic infusion of nitro-oleic 
acid; the latter resulting in elevation of epoxyeicosatrienoic acid (EET) substrates, which 
lowered BP in an angiotensin II-induced hypertension model [80].  
 
Bondonno et al. found no additive effects of the combination of flavonoid-rich apple and 
spinach on plasma nitrite or RXNO, endothelial function, or blood pressure in healthy 
volunteers [81].  Rodriguez-Mateos, et al. explored the combination of nitrate and cocoa 
flavanols [82]. They found an increase in FMD peaking at 1 hour with lower doses (3 mg/kg 
body weight of cocoa flavanols and 2.7 mg/kg nitrate), relative to the additive effect of each 
agent separately; however such an effect was not found at higher doses of each (10.9 mg/kg 
cocoa flavanols with 8.5 mg/kg nitrate).  The improvement in FMD was coupled with an 
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increase in nitrate related gastric NO (compared to nitrate alone), but attenuation in plasma 
nitrite.  
Dietary polyphenols, including those found in red wine, possess nitrite reductase activity, 
which may enhance NO production in the stomach, and potentially in the circulation; 
examples of such polyphenols are provided in Table 2 [59] [83] [84]. A further mechanism 
through which wine may result in a vasodilatory effect is through the formation of ethyl nitrite, 
from the nitrosation of ethanol [85]. Finally, other factors, such as a healthy outdoor lifestyle 
in a sunny climate may improve blood pressure through the mobilisation of nitrite from the 
skin and dermal vasculature into the circulation by UVA irradiation [86] [87]. Whilst the blood 
pressure lowering effect of UVA irradiation does not appear to be enhanced with dietary 
nitrate; Muggeridge et al have recently shown that the combination (of dietary nitrate with 
UVA irradiation) improves oxygen efficiency during steady-state exercise, and exercise 
performance in a time trial [88]. 
 
Conclusion 
We have described important recent developments in the understanding of mechanisms 
relating to, and potential therapeutic uses of the nitrate-nitrite-NO pathway. These are 
summarised in Table 3, and include nitrite’s and nitrate’s effects on inhibiting platelets, 
minimising IRI, the lack of problems with tolerance, improving mitochondrial function and 
exercise performance, normoxia-dependent dilatation, the potential of dietary nitrate 
containing vegetables to reduce the risk of certain cancers, and potentially beneficial 
combinations of dietary nitrate with other components of a healthy diet, and lifestyle such as 
the Mediterranean diet.  Further studies are needed to determine the long-term beneficial 
effects of dietary nitrate. By furthering the understanding the nitrate-nitrite-NO pathway, 
additional inexpensive dietary and therapeutic approaches could be developed for the 
treatment and prevention of disease.  
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Table 1. ‘Nitrate-Cancer Risk Veg-Table’ showing the amount of nitrate (in mmol, or ‘units’) 
of various vegetables, per UK portion (80 g) and the associated strong evidence decreased 
risk of cancer of according to the World Cancer Research Foundation (WCRF).  
Nitrate 
Units  
(mmol) 
Vegetables  
1 UK Portion (80 g) 
WCRF: Strong Evidence for 
Decreased Risk of Cancer of:  
High              
~2           
(>1000 
mg/kg) 
Spinach, lettuce 
 
Mouth, pharynx, larynx, oesophagus, 
stomach 
Rocket, beetroot, celery, fennel, 
Chinese cabbage, radish 
 
Medium   
~1/2          
(100-1000 
mg/kg) 
Kale, turnip, cabbage, green 
beans, cucumber, carrot, leek, 
sweet pepper  
Mouth, pharynx, larynx, oesophagus, 
stomach 
Spring onion, garlic Stomach 
Low         
~1/10       
(<100 
mg/kg) 
Onion 
 
Stomach 
Tomato Mouth, pharynx, larynx, oesophagus, 
stomach 
Low ~1/10  
(<100 mg/l) 
Water (250 ml): tap water 
 
 
Very Low 
~1/100      
(<10 mg/l) 
Mineral water 
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Table 2. Nitrate-dietary/lifestyle Combinations. Evidence for potentially beneficial 
combinations of dietary nitrate with other common components of the Mediterranean 
diet/lifestyle. 
Additional 
component 
Effect of additional dietary/lifestyle component in combination with 
dietary nitrate/nitrite 
Ascorbic acid 
(vitamin C) 
 Reducing agent: enhance nitrite reduction to NO and vasorelaxation 
[69] 
 Inhibit N-nitrosamine formation [53] 
 Decreases gastro-oesophageal cancer risk [52] 
Oleic acid 
(Olive oil) 
 
& 
 
Conjugated 
Linoleic acid 
(e.g. milk 
from 
ruminants) 
 Form nitro-fatty acids: nitro-oleic acid and nitro-linoleic acid:  
 anti-inflammatory properties (inhibiting neutrophils, platelets and 
macrophages) – e.g. in model of colitis, [72]  
 S-alkylation of nuclear factor κB (resulting in inhibition of macrophage 
cytokine and iNOS expression) [74]  
 and peroxisome proliferator-activated receptor-γ (PPAR-γ) [72, 73], 
 reduced atherosclerotic lesion formation in apoliproprotein E-deficient 
mice (reduced foam cell formation/ oxidised LDL-induced 
phosphorylation of signal transducer and activator of transcription-1 
(STAT-1) [75];  
 inhibition of soluble epoxide hydrolase (sEH) with accumulation of  
epoxyeicosatrienoic acid (EET) substrates which lowered BP in 
angiotensin II-induced hypertension model [80] 
Cocoa 
flavanols 
 low dose cocoa (3 mg/kg) with nitrate (2.7 mg/kg) increased flow 
mediated dilatation [82] 
Red wine 
polyphenols 
 anthocyanin fraction and catechol (caffeic acid) enhance nitrite 
reduction to NO in the stomach [59] 
Dietary 
phenols 
 nitrite reductase activity:  
 epicatechin-3-O-gallate, quercetin, procyanidin B8 dimer, oleuropein, 
procyanidin B2 dimer, chlorogenic acid, epicatechin, catechin, 
procyanidin B5 dimer [83];  
 Hawthorn berry extract [84] 
Alcohol  ethanol is nitrosated forming ethyl nitrite, a potent vasodilator [85]; 
 inhaled ethyl nitrite improves arterial oxygenation and haemodynamics 
in persistent pulmonary hypertension of the newborn [89] 
Sunlight UVA 
irradiation 
 UVA mobilises nitrite from the skin and dermal vasculature [86] 
 UVA increases circulating  nitrite concentration and lowers blood 
pressure [87] 
 UVA + nitrate supplementation reduces VO2 during steady-state 
exercise and improves performance in a time trial [88] 
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Table 3. Twists and turns in the realisation of the nitrate-nitrite-NO pathway. Complete Table 
including the earlier questions covered in Part I. 
 Negative/Neutral  Positive  
Background to nitrate’s (NO3
-) 
& nitrite’s (NO2
-) properties? 
Physiologically inert 
metabolites of NO [90] 
 
1. Is nitrite a source of NO?  No – nitrite is a 
physiologically inert 
metabolite of NO [90] 
Yes – in the ischaemic 
heart: Zweier et al.,1995 
[91] 
2. What effect does nitrite 
have in IRI? 
Deleterious - Zweier et al., 
1995 [91] 
Protective - Webb et al., 
2004  
3. Does nitrite dilate blood 
vessels?  
No – Lauer et al., 2001 [92] Yes - Modin et al., 2001 
[69], Cosby et al., 2003  
4. Are there nitrite 
reductases?  
Non-enzymatic/non-NOS  
Zweier et al.,1995 [91] 
Hb [34], Mb [93], XOR [1], 
AO [94], eNOS [95]  
5. Is nitrate a source of NO?   Benjamin et al., 1994 [96], 
Lundberg et al.,1994 [97] 
6. Does nitrate inhibit 
platelets? 
 Yes – McKnight et al., 1999 
[98] 
7. Does nitrate inhibit platelets 
via SNOs?  
No? – Richardson et al., 
2002 [99] 
 
8. Does nitrate increase 
plasma nitrite?  
No - Pannala et al., 2003 
[100] 
Yes – Lundberg et al., 2004 
[101], Webb et al., 2008 [2] 
9. Does nitrate lower BP?   Yes – Larsen et al., 2006 
[102], Webb et al., 2008 [2] 
10. Does nitrate lower BP via 
nitrite?   
 Yes – Webb et al., 2008 [2] 
11. Is nitrate protective in IRI?  Yes – Webb et al., 2008 [2] 
12. Does nitrite inhibit 
platelets? 
No – Bryan et al., 2005 [4] Yes – Webb et al., 2008 [2] 
13. Does nitrate/nitrite exhibit 
tolerance? 
 
No – Dejam et al., 2007 [9]; 
Vanhatalo et al., 2010 [11]; 
Sobko et al., (2010) [10]; 
Kapil et al., [12] 
 
14. Do nitrate/nitrite alter  Yes – exercise – Larsen 
2007 [19], 2011 [21], Bailey 
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mitochondrial metabolism?  2009 [18] 
15. Is nitrite bioactivation 
hypoxia dependent?  
Yes – most of field [103] Not always – Omar 2015 
[35] 
16. Is nitrate-derived nitrite 
harmful?  
Yes – carcinogenic 
potential - early studies 
[104] 
No definite association  
Bryan [43] 
17. Other therapeutic 
opportunities for nitrate-nitrite 
 Subarachnoid 
haemorrhage [60]; 
pulmonary arterial 
hypertension [62] 
18. Are there potentially 
beneficial dietary 
combinations? 
Ascorbic acid, oleic acid, 
conjugated linoleic acid, 
cocoa flavanols, dietary 
and red wine polyphenols, 
alcohol, sunlight 
 
 
 
